All Business articles – Page 11
-
BusinessUS supreme court ends Sandoz–Amgen biosimilar dispute
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
-
BusinessWhat might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
BusinessCoca-Cola chemist convicted of trade secret theft
Xiaorong You stole files detailing BPA-free can coatings from seven major chemicals firms
-
BusinessFatal explosion at US paint and polymers plant
One dead and nine others injured as building partially collapsed after explosion and fire
-
BusinessGovernment clears merger of SinoChem and ChemChina
China’s chemicals giants will unite under a state-run holding company
-
BusinessMaking supercritical fluid extraction affordable with Nova Extraction
London-based duo wants this powerful technique to be cheaper and more widely accessible
-
BusinessAntibody–drug conjugates drive growth in oncology
Antibody–drug conjugates are coming of age and pharma is investing, reports Katrina Megget
-
BusinessWhy manufacturing Covid vaccines at scale is hard
Exploring the pinch points vaccine makers face as they ramp up production
-
BusinessUniversity team’s silica coats stop vaccines spoiling at room temperature
Asel Sartbaeva hopes her pioneering ensilication technology will be adopted to store and transport pediatric vaccines to low-income countries
-
BusinessChromosol’s silicon photonics system tackles data transfer bottleneck
Technology for integrating lasers directly into photonic circuits could accelerate replacement of large and expensive optical systems
-
BusinessPolar storm paralyses US Gulf Coast petrochemical sector
Days after ‘icepocalypse’ hit Texas, 75% of US ethylene capacity was still offline, as was 70% of its polypropylene and 40% of propylene production
-
BusinessCoronavirus variants stymie success of monoclonal antibodies
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
-
BusinessBASF tightens austerity belt and closes plant in north of England
Political fallout over £1 billion Covid loan that preceded hexamethylene diamine plant closure
-
BusinessBiggest venture yet of any pharma company into cannabis
Jazz Pharmaceuticals buys cannabinoid therapeutic firm for $7.2 billion, inheriting first plant-derived cannabinoid medicine ever approved by FDA
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
BusinessPatent applications listing AI as an inventor run into legal problems
Artificial intelligence is increasingly being used to find new chemical compounds and repurpose drugs, but should laws be updated to protect the intellectual property of such discoveries?
-
BusinessHoxton Farms grows animal fat for meat substitutes
Covid-19 pandemic motivated friends to combine their expertise in cell biology and mathematical modelling, and realise company they had being discussing for years
-
BusinessDuPont and spinoffs reach $4bn settlement to resolve PFAS liability issues
DuPont, Chemours and Corteva have also reached an $83mn agreement to settle 95 pending personal injury cases in Ohio related to PFAS
-
BusinessCan chemistry thaw the vaccine cold chain?
Covid-19 has highlighted the challenges of storing vaccines at their proper temperature. Angeli Mehta explores how scientists are trying to protect vaccines from heat degradation
-
BusinessVaccine approvals offer hope as global Covid cases surge
A handful of vaccines are now approved and the first doses are being given to patients, with trials for many more candidates nearing completion